Navigation Links
Ezy-Close Post-op Shoe

ProductsEzy-Close Post-op Shoe
Company AliMed, Inc.
Item Ezy-Close Post-op Shoe
Features 
  • A black post-op shoe that blends in with dress clothes
  • This soft, lightweight, breathable nylon mesh upper closes easily with a single touch to the Velcro® flap
  • No straps or D-rings
  • The insole is lightly padded for comfort
  • Semirigid, skid-proof outersole offers a rockered toe and heel for more natural gait
  • Sold individually
  • Fits left or right
  • Description Ezy-Close Post-op Shoe The shoe your patients have been asking for: a black post-op shoe that blends in with dress clothes. This soft, lightweight, breathable nylon mesh upper closes easily with a single touch to the Velcro® flap. No straps or D-rings. The insole is lightly padded for comfort. Semirigid, skid-proof outersole offers a rockered toe and heel for more natural gait. Sold individually. Fits left or right.
    Info AliMed, Inc.
    Customer Service: (800) 225-2610
    Web site: http://www.alimed.com/

    Related medicine products :

    1. Royce Ear Knife
    2. Pressure Ridge Single Plate Molteno Implant (D1)
    3. Pressure Ridge Double Plate Molteno Implant (DR2/DL2)
    4. Ventrix™ NL950-100 Intercranial Pressure Monitoring System
    5. Sophy Adjustable Pressure Valves
    6. WaveMap™ & SmartWire™ Pressure System
    7. Smartmap Pressure Instrument
    8. Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-721
    9. Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-771
    10. Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-771S
    11. Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters with Lumen; SPC-770
    Kinetic and endpoint methods for the quantitative determination of creatinine in serum....
    For the qualitative determination of magnesium in serum....
    For the quantitative determination of total glucose in human serum....
    Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
    Medicine Products:
    (Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
    (Date:6/24/2017)... ... June 24, 2017 , ... ... at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable ... that visits to the dentist fit into their patients’ busy lifestyles. Dental365 also ...
    (Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
    (Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
    (Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
    Breaking Medicine News(10 mins):
    (Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
    (Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
    (Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
    Breaking Medicine Technology: